These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 615765)

  • 1. [Microbiological characteristics of kanendomycin].
    Blandino G; Mattina R; Speciale A; Toscano MA
    G Ital Chemioter; 1977; 24(1-2):7-10. PubMed ID: 615765
    [No Abstract]   [Full Text] [Related]  

  • 2. [Amikacin: a new semisynthetic aminoside antibiotic derivative of kanamycin A. Action spectrum].
    Periti P; Lamanna A; Nicoletti I; Mazzei T; Polito P
    G Ital Chemioter; 1975; 22(1-2):75-86. PubMed ID: 1235358
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experimental study of the antibacterial activity and chemotherapeutic effectiveness of amikacin sulfate].
    Lobuseva AN; Kuznetsova SM; Samoĭlova LN
    Antibiot Med Biotekhnol; 1985 Oct; 30(10):776-80. PubMed ID: 4091515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Phenotypes of resistance to aminosides and sensitivity of amikacin in hospitals].
    Witchitz JL; Golstein FW; Pangon B; Christol D; Acar JF
    Nouv Presse Med; 1979 Oct; 8(42):3417-20. PubMed ID: 537886
    [No Abstract]   [Full Text] [Related]  

  • 5. [Sensitivity of gram-negative germs to Amikacin].
    Redjeb SB; Ennaifer M; Bissardon O; Ben Salah N; Boujnah A
    Tunis Med; 1979; 57(2-3):103-6. PubMed ID: 553336
    [No Abstract]   [Full Text] [Related]  

  • 6. [Study of the microbiological activity in vitro of BB-K-8, a new aminoglycoside antibiotic].
    Ravagnan G; Rasura M; Piccolomini R
    Boll Soc Ital Biol Sper; 1976 Sep; 52(18):1440-6. PubMed ID: 1024552
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro evaluation of ceftazidime (GR 20263), amikacin and sisomicin, in a model simulating serum pharmacokinetics of therapeutic doses.
    Xerri L; Orsolini P; Broggio R
    Chemioterapia; 1984 Oct; 3(5):271-7. PubMed ID: 6398124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Microbiology and pharmacokinetics of gentamicin, sisomicin, netilmicin and amikacin].
    Naumann P; Rosin H
    Adv Clin Pharmacol; 1978; 15():23-34. PubMed ID: 676876
    [No Abstract]   [Full Text] [Related]  

  • 9. [Possible errors in the interpretation of bacterial sensitivity to aminoglycoside antibiotics].
    García Hierro P; Ponte Miramontes MC; Soriano García F
    Rev Clin Esp; 1980 Oct; 159(2):87-90. PubMed ID: 7209044
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro susceptibility of gram negative bacteria to amikacin and its comparison with three other aminoglycoside antibiotics.
    Daniel J; Thomas M; Shanmugam J
    Indian J Pathol Microbiol; 1985 Apr; 28(2):115-9. PubMed ID: 3835114
    [No Abstract]   [Full Text] [Related]  

  • 11. [Combined effect of cefotaxime and aminoglycoside antibiotics on Pseudomonas strains and group D streptococci].
    Linda H; Patzer J
    Med Dosw Mikrobiol; 1984; 36(4):223-9. PubMed ID: 6100122
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to aminoglycoside antibiotics.
    Ramírez-Ronda CH; Nevárez M; Gutiérrez-Núñez JJ; Reyes Y
    Bol Asoc Med P R; 1983 Jul; 75(7):305-7. PubMed ID: 6442865
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative study of the effect of sisomicin and other aminoglycosides on the causative agents of surgical infection].
    Navashin PS
    Antibiotiki; 1982 Dec; 27(12):26-9. PubMed ID: 6819812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of glycodiversification: expedient synthesis and antibacterial evaluation of a library of kanamycin B analogues.
    Li J; Wang J; Czyryca PG; Chang H; Orsak TW; Evanson R; Chang CW
    Org Lett; 2004 Apr; 6(9):1381-4. PubMed ID: 15101747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial activity of netilmicin in comparison with gentamicin, sisomicin, tobramycin, and amikacin and their resistance patterns.
    Braveny I; Voeckl J; Machka K
    Arzneimittelforschung; 1980; 30(3):491-5. PubMed ID: 7387761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sensitivity to kanendomycin in vitro of gram-negative bacterial strains].
    Carbone M; Focà A; Merendino R; De Rosa M
    G Ital Chemioter; 1977; 24(1-2):103-8. PubMed ID: 615751
    [No Abstract]   [Full Text] [Related]  

  • 17. [The antimicrobial activity of amikacin in comparison with three other aminoglycoside-antibiotics (author's transl)].
    Jotzoff M
    Med Klin; 1978 Jun; 73(24):914-7. PubMed ID: 661734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The susceptibility of recently isolates of gram-negative bacteria to amikacin and other aminoglycosides.
    Lexomboon U; Duangmani C; Srimunta C
    J Med Assoc Thai; 1979 Oct; 62(10):544-9. PubMed ID: 501262
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies on the in vitro antibacterial activities of homemade amikacin on the common bacterial pathogens].
    Wang QN; Jiang YF; Du JZ; Luo MY; Liu YH; Xu ZM
    Yao Xue Xue Bao; 1982 May; 17(5):321-6. PubMed ID: 7180464
    [No Abstract]   [Full Text] [Related]  

  • 20. [Topical and microbiological evaluation of dideoxykanamycin B in comparison to other second and third generation aminoglycosides].
    Nicoletti G; Russo G; Toscano MA; Gismondo MR; Mattina R
    G Ital Chemioter; 1979; 26(1-2):167-72. PubMed ID: 554806
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.